Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03082963 · ClinicalTrials.gov registry record · NA
Mapping Electrogram Morphology Recurrence for Atrial Fibrillation Ablation
A NA study of Atrial Fibrillation, sponsored by Jeffrey Goldberger.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT03082963 is a NA study of Atrial Fibrillation that has completed, run by Jeffrey Goldberger. The registered enrollment target is 10 participants, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03082963, a NA study of Atrial Fibrillation, has completed, sponsored by Jeffrey Goldberger.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall goal of this project is to test the feasibility of performing real-time electrogram morphology recurrence (EMR) mapping in patients with persistent atrial fibrillation (AF) to locate areas of high electrogram morphology recurrence rate. The Investigator believe that the EMR mapping can be integrated into cardiac mapping and used to identify potential sites for ablation. Furthermore, this study could help demonstrate the efficacy of this technology's ability to terminate or slow AF. The Investigator will test this technology on ten subjects undergoing a second ablation procedure. The Investigator will map the AF utilizing the EMR to indicate locations of stable activity and ablate the area. The Investigator believes that the study could produce acute AF termination or AF cycle length slowing. In addition to testing the real-time electrogram morphology recurrence mapping, the study would also like to determine the acute effects of radiofrequency ablation of areas of high recurrence rates and determine long term freedom from AF following ablation of areas of high recurrence rates.
Conditions Studied
Interventions
- DEVICE Electrogram Morphology Mapping (EMR)
Study Locations (1)
Florida
- University of Miami - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2017-04-04 |
| Est. Completion | 2022-06-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03082963
The ClinicalTrials.gov registry entry for NCT03082963 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (100% lower). The listed sponsor is Jeffrey Goldberger, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which Electrogram Morphology Mapping (EMR) is the first listed.
NCT03082963 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT03082963 about?
NCT03082963 is a clinical study titled "Mapping Electrogram Morphology Recurrence for Atrial Fibrillation Ablation". The overall goal of this project is to test the feasibility of performing real-time electrogram morphology recurrence (EMR) mapping in patients with persistent atrial fibrillation (AF) to locate areas of high electrogram morphology recurrence rate. The Investigator believe that the EMR mapping can b...
What is the current status of trial NCT03082963?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2017-04-04. Estimated completion is 2022-06-18.
What conditions does trial NCT03082963 study?
This clinical trial studies the following conditions: Atrial Fibrillation.
What interventions are being tested in trial NCT03082963?
The interventions under investigation include: Electrogram Morphology Mapping (EMR) (DEVICE).
Who is sponsoring clinical trial NCT03082963?
This trial is sponsored by Jeffrey Goldberger, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03082963 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Renal Denervation + PVI vs PVI Alone for Persistent AF
RECRUITING · NA
-
Pericardiotomy in Cardiac Surgery
RECRUITING · NA
-
CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation
RECRUITING · NA
-
The CONFORM Pivotal Trial
RECRUITING · NA
-
Vascular Closure With a Device Compared to Manual Compression After Atrial Fibrillation Ablation: The LockeT II Study
RECRUITING · NA
-
The Fourth Left Atrial Appendage Occlusion Study
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.